<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Central Nervous System Agents: Antidepressants & Anticonvulsants</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pharmacology-cardiovascular-agents-angina-dyslipidemia-diuretics.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 73%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 8 of 11</span> <!-- Update text -->
                    </div>
                    <a href="pharmacology-cns-agents-anesthetics-analgesics.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Central Nervous System Agents: Antidepressants & Anticonvulsants</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">

                <!-- START: cns-neurotransmitters -->
                <section id="cns-neurotransmitters" class="content-section" aria-labelledby="section-heading-cns-neurotransmitters">
                    <h2 id="section-heading-cns-neurotransmitters" class="section-heading">
                         <span class="heading-icon">üß†</span>
                        <span class="heading-text">Major Neurotransmitters</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Acetylcholine (ACh)</h3>
                        <ul>
                            <li>Smooth muscle, cardiac muscle, and exocrine glands</li>
                            <li>Anticholinergics block ACh receptors</li>
                        </ul>

                        <h3 class="subsection-heading">GABA (gamma-aminobutyric acid)</h3>
                        <ul>
                            <li>Regulates message delivery system of the brain</li>
                        </ul>

                        <h3 class="subsection-heading">Dopamine</h3>
                        <ul>
                            <li>Acts on the CNS and kidneys</li>
                        </ul>

                        <h3 class="subsection-heading">Epinephrine</h3>
                        <ul>
                            <li>Acts on cardiac and bronchodilator receptors</li>
                            <li>Known as Adrenaline</li>
                        </ul>

                        <h3 class="subsection-heading">Serotonin</h3>
                        <ul>
                            <li>Acts on smooth muscle and gastric mucosa (causes vasoconstriction)</li>
                            <li>Emotional responses: depression, anxiety</li>
                        </ul>

                        <h3 class="subsection-heading">Communication by Neurotransmitters</h3>
                        <figure>
                            <img src="../assets/images/2025_06_04_388f472fe00173f74572g-24-1.jpg" alt="Diagram illustrating communication by neurotransmitters, showing release from one axon and reception by another neuron's dendrites." class="content-image">
                            <figcaption>Neurotransmitters are released from one axon and received by another neuron's dendrites.</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: cns-neurotransmitters -->

                <!-- START: anticholinergic-effects -->
                <section id="anticholinergic-effects" class="content-section" aria-labelledby="section-heading-anticholinergic-effects">
                    <h2 id="section-heading-anticholinergic-effects" class="section-heading">
                         <span class="heading-icon">üö´</span>
                        <span class="heading-text">Anticholinergic Side Effects</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Decreased GI motility</li>
                            <li>Decreased sweating</li>
                            <li>Decreased urination</li>
                            <li>Dilated pupils</li>
                            <li>Dry eyes</li>
                            <li>Dry mouth</li>
                        </ul>
                    </div>
                </section>
                <!-- END: anticholinergic-effects -->

                <!-- START: antidepressants -->
                <section id="antidepressants" class="content-section" aria-labelledby="section-heading-antidepressants">
                    <h2 id="section-heading-antidepressants" class="section-heading">
                         <span class="heading-icon">üòä</span>
                        <span class="heading-text">I: ANTI-DEPRESSANTS</span>
                    </h2>
                    <div class="content-card">
                        <p>All current antidepressants affect the serotonin and/or noradrenaline systems in the brain.</p>
                        <p>Their effect on monoamine availability is immediate, but the clinical response occurs after about 3 weeks.</p>
                        <p>About 10% of depression becomes chronic & requires regular follow up.</p>

                        <h3 class="subsection-heading">COMMONLY USED ANTIDEPRESSANT DRUGS</h3>

                        <h4 class="subsubsection-heading">1. Tricyclics</h4>
                        <p><strong>Mxn:</strong> block re-uptake of both noradrenaline and serotonin into pre-synaptic nerve terminals.</p>
                        <p>e.g. Amitriptyline, Clomipramine, Imipramine</p>
                        <p>Others: trimipramine, maproptiline, Mianserine</p>
                        <p><strong>Adm:</strong> all per oral, with food to avoid GIT irritation.</p>
                        <p>If a dose is missed, DON'T double the next dose.</p>
                        <p><strong>S/E:</strong></p>
                        <ul>
                            <li>Sedation</li>
                            <li>Seizures (clomipramine & maproptiline)</li>
                            <li>CVS: hypotension, tachycardia</li>
                            <li>Decreased libido, orgasmic dysfunction in females.</li>
                            <li>Weight gain (increased appetite)</li>
                            <li>Blurred vision, dry mouth, aggravation of glaucoma, urinary retention</li>
                            <li>CNS: agitation, confusion, memory lapse, hallucinations.</li>
                        </ul>
                        <p><strong>C/I:</strong></p>
                        <ul>
                            <li>Acute Myocardial infarction, Alcoholism.</li>
                            <li>Pregnancy & lactation</li>
                            <li>Glaucoma & epilepsy</li>
                            <li>Lethal in overdose due to uncontrolled seizures, arrythmias, hypotension.</li>
                        </ul>

                        <h4 class="subsubsection-heading">2. Selective Serotonin Re-uptake Inhibitors (SSRIs)</h4>
                        <p><strong>Mxn:</strong> selectively inhibits the re-uptake of serotonin hence increasing its levels in the synaptic cleft. Has anxiolytic effect.</p>
                        <p>Include: Fluoxetine (prozac), Paroxetine, Citalopram, Sertraline.</p>
                        <p><strong>Adm:</strong> all adminstered per oral.</p>
                        <p><strong>S/E:</strong></p>
                        <ul>
                            <li>Nausea, vomiting & diarrhoea</li>
                            <li>Tremors, restlessness</li>
                            <li>Dizziness, headache, insomnia</li>
                            <li>Reduced libido, ejaculation delay.</li>
                            <li>Excessive sweating.</li>
                        </ul>
                        <p><strong>Advantages of SSRIs:</strong></p>
                        <ul>
                            <li>Fewer S/E than heterocyclics</li>
                            <li>No weight gain</li>
                            <li>Much safer than heterocyclics in overdose.</li>
                        </ul>

                        <h4 class="subsubsection-heading">3. Monoamine Oxidase Inhibitors (MAOIs)</h4>
                        <p><strong>Mxn:</strong> inhibition of enzyme MAO causing an increase in noradrenaline, dopamine & serotonin in the storage sites in CNS.</p>
                        <p><strong>a). Irreversible nonselective MAOIs</strong></p>
                        <p>e.g. Phenelzine, Tranylcypromine</p>
                        <p><strong>b). Reversible Inhibitors of MAO</strong></p>
                        <p>e.g. Maclobemide</p>
                        <p><strong>S/E of MAOIs:</strong></p>
                        <ul>
                            <li>Dizziness, tiredness & weakness</li>
                            <li>Diarrhoea</li>
                            <li>Unusual excitement or nervousness</li>
                            <li>Tachycardia</li>
                            <li>Dark urine, difficulty urinating</li>
                            <li>Headache, blurred vision, difficulty sleeping.</li>
                            <li>Decreased libido</li>
                        </ul>
                        <p><strong>C/I:</strong> Cardiovascular disease, severe liver & renal function impairment</p>
                        <p><strong>Precaution:</strong> Pregnancy, lactation, paediatrics & geriatrics. Use with care in suicidal patients</p>
                        <aside class="callout warning" role="alert">
                            <h4 class="callout-title"><span class="callout-icon">‚ö†Ô∏è</span> Important Note for MAOIs</h4>
                            <p>Avoid tyramine containing foods e.g. alcohol, broad beans, chocolate, cream & yoghurt, cheese.</p>
                        </aside>

                        <h3 class="subsection-heading">GENERAL USES OF ANTIDEPRESSANTS</h3>
                        <ul>
                            <li>Major depression</li>
                            <li>Obsessive-compulsive disorder (SSRIs & clomipramine)</li>
                            <li>Panic disorder</li>
                            <li>Bulimia (SSRIs)</li>
                            <li>Social phobia</li>
                            <li>Enuresis (involuntary passage of urine)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: antidepressants -->

                <!-- START: anticonvulsants -->
                <section id="anticonvulsants" class="content-section" aria-labelledby="section-heading-anticonvulsants">
                    <h2 id="section-heading-anticonvulsants" class="section-heading">
                         <span class="heading-icon">‚ö°</span>
                        <span class="heading-text">II: ANTICONVULSANTS (ANTIEPILEPTIC) DRUGS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Mechanisms of Action</h3>
                        <ul>
                            <li><strong>GABA potentiation:</strong> Diazepam, phenobarbitone, gabapentin, tiagabine, vigabatrin. Gamma-aminobutyric-acid (GABA) is an inhibitory neurotransmitter that is found in great quantity in the brain.</li>
                            <li><strong>Na+ ion channel block:</strong> Carbamazepine, phenytoin, valproic acid, high doses of phenobarbitone.</li>
                            <li><strong>Ca<sup>2+</sup> ion channel block:</strong> ethosuximide & valproic acid</li>
                            <li><strong>Glutamic acid antagonism:</strong> Felbamate, lamotrigine, topiramate. Glutamate is the most abundant excitatory neurotransmitter in the brain.</li>
                        </ul>

                        <h3 class="subsection-heading">Classification of antiepileptics</h3>
                        <ul>
                            <li><strong>Older antiepileptics:</strong> Carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, valproic acid</li>
                            <li><strong>Newer antiepileptics:</strong> Felbamate, gabapentin, lamotrigine, tiagabine, topiramate, vigabatrin</li>
                        </ul>

                        <h4 class="subsubsection-heading">CARBAMAZEPINE</h4>
                        <p><strong>Adm:</strong> per oral.</p>
                        <p><strong>Uses:</strong> Partial & Tonic-clonic seizures. Also used in trigeminal neuralgia & bipolar disorder.</p>
                        <p><strong>Toxicities:</strong> CNS depression (diplopia, ataxia, drowziness). Hematotoxicity -agranulocytosis. Liver enzyme inducer. Teratogenic.</p>

                        <h4 class="subsubsection-heading">PHENYTOIN</h4>
                        <p><strong>Adm:</strong> per oral with variable absorption.</p>
                        <p>Competition for plasma protein binding.</p>
                        <p>Induction of drug metabolizing enzymes.</p>
                        <p><strong>Uses:</strong> Partial & tonic-clonic seizures.</p>
                        <p><strong>Toxicities:</strong> CNS depression. Hirsutism, gingival hyperplasia, osteomalacia. Teratogenicity (craniofacial anomalies)</p>

                        <h4 class="subsubsection-heading">VALPROIC ACID</h4>
                        <p><strong>Adm:</strong> per oral.</p>
                        <p><strong>Uses:</strong> ("Broad spectrum" Antiepileptic drug) used in: Absence seizures, Myoclonic, partial, & tonic-clonic seizures. Also used in bipolar disorder & migraine.</p>
                        <p><strong>Toxicities:</strong> GI distress. Hepatotoxicity, inhibition of drug metabolism. Teratogenicity (spina bifida)</p>

                        <h4 class="subsubsection-heading">OTHER OLDER ANTIEPILEPTIC DRUGS</h4>
                        <p><strong>Clonazepam:</strong> Used in myoclonic seizures, anxiety states, bipolar disorder. Causes sedation & dependence.</p>
                        <p><strong>Ethosuximide:</strong> Only used in absence seizures. May cause GI distress, lethargy, headache.</p>
                        <p><strong>Phenobarbital:</strong> Used in tonic-clonic seizures & partial seizures. Causes CNS depression, dependence, liver enzyme induction.</p>

                        <h4 class="subsubsection-heading">NEWER ANTIEPILEPTIC DRUGS</h4>
                        <ul>
                            <li><strong>Felbamate:</strong> Back-up in partial seizures & myoclonic seizures.</li>
                            <li><strong>Gabapentin:</strong> Used in partial seizures, bipolar disorder, neuropathic pain, migraine</li>
                            <li><strong>Lamotrigine:</strong> Used in absence & partial seizures, & bipolar disorder.</li>
                            <li><strong>Vigabatrin:</strong> Back-up in partial seizures</li>
                            <li><strong>Topiramate, tiagabine:</strong> Back-up in partial seizures.</li>
                        </ul>

                        <h3 class="subsection-heading">Treatment Principles</h3>
                        <ul>
                            <li>Use a single drug whenever possible and increase its dose to either seizure control or toxicity.</li>
                            <li>If a drug fails to control seizures, switch to another appropriate drug used alone and again increase the dose until seizure control occurs or toxicity intervenes.</li>
                            <li>Use two drugs only when monotherapy has failed. Some patients may have more seizures when taking two drugs, compared with one drug, because of drug interactions.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: anticonvulsants -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="pharmacology-cardiovascular-agents-angina-dyslipidemia-diuretics.html" class="nav-button">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 73%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 8 of 11</span> <!-- Update text -->
                    </div>
                    <a href="pharmacology-cns-agents-anesthetics-analgesics.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script> <!-- Basic JS for disabled links etc. -->
</body>
</html>